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The APC-associated protein EB1 associates with components of
the dynactin complex and cytoplasmic dynein intermediate chain
Lisbeth Berrueta*, Jennifer S. Tirnauer, Scott C. Schuyler, David Pellman 
and Barbara E. Bierer†
Human EB1 is a highly conserved protein that binds to
the carboxyl terminus of the human adenomatous
polyposis coli (APC) tumor suppressor protein [1], a
domain of APC that is commonly deleted in colorectal
neoplasia [2]. EB1 belongs to a family of microtubule-
associated proteins that includes Schizosaccharomyces
pombe Mal3 [3] and Saccharomyces cerevisiae Bim1p
[4]. Bim1p appears to regulate the timing of cytokinesis
as demonstrated by a genetic interaction with Act5, a
component of the yeast dynactin complex [5]. Whereas
the predominant function of the dynactin complex in
yeast appears to be in positioning the mitotic spindle [6],
in animal cells, dynactin has been shown to function in
diverse processes, including organelle transport,
formation of the mitotic spindle, and perhaps cytokinesis
[7–10]. Here, we demonstrate that human EB1 can be
coprecipitated with p150Glued, a member of the dynactin
protein complex. EB1 was also found associated with
the intermediate chain of cytoplasmic dynein (CDIC) and
with dynamitin (p50), another component of the dynactin
complex, but not with dynein heavy chain, in a complex
that sedimented at approximately 5S in a sucrose
density gradient. The association of EB1 with members
of the dynactin complex was independent of APC and
was preserved in the absence of an intact microtubule
cytoskeleton. The molecular interaction of EB1 with
members of the dynactin complex and with CDIC may be
important for microtubule-based processes.
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Results and discussion
We screened for EB1-associated proteins using recombi-
nant human EB1 fused to glutathione-S-transferase (GST).
From lysates prepared from metabolically labeled Jurkat T
lymphocytes, we precipitated a 150 kDa protein
(Figure 1a) with GST–EB1 but not with GST alone, nor
with two unrelated GST-fusion proteins (Figure 1a and
data not shown). Microsequencing of four tryptic peptides
of this 150 kDa protein demonstrated it to be identical to
p150Glued (data not shown). The identity of the protein and
its association with EB1 in Jurkat T cells was confirmed by
immunoprecipitation using an anti-EB1 monoclonal anti-
body followed by western blotting with an anti-p150Glued
antibody (Figure 1b). Reciprocal precipitation using a poly-
clonal anti-p150Glued antibody followed by western blotting
for EB1 also demonstrated the interaction (Figure 1d).
Immunoprecipitations using an anti-EB1 monoclonal anti-
body were performed in order to determine whether other
members of the 20S dynactin complex were associated
with human EB1. These experiments demonstrated that
EB1 associated with cytoplasmic dynein intermediate
chain (CDIC; Figure 1c) but not with cytoplasmic dynein
heavy chain (CDHC; data not shown). Because dynamitin
migrates at approximately 50 kDa on SDS gels and is
therefore masked by the heavy chain of the anti-EB1 anti-
body that we used for immunoprecipitation, we used the
GST–EB1 fusion protein to probe the EB1–dynamitin
interaction. The GST–EB1 fusion protein, but not GST
alone, precipitated dynamitin (Figure 1e) from Jurkat-cell
lysates. GST–EB1 also failed to precipitate CDHC from
cell lysates. Whether CDHC is absent from this complex,
or whether the specific conditions of precipitation (or
detection) disrupted an in vivo EB1–CDHC association,
could not be determined. 
To define further the interaction of EB1 with p150Glued
and CDIC and to confirm the specificity of this associa-
tion, recombinant GST–EB1 fragments containing the
EB1 amino-terminal domain (amino acids 1–135), middle
portion (amino acids 69–202) or carboxy-terminal domain
(amino acids 136–268) were used in precipitation experi-
ments (Figure 1f). This analysis demonstrated that the
carboxyl terminus of EB1 was required for binding to
p150Glued and to CDIC (Figure 1f); but note that none of
the interactions are necessarily direct.
The vertebrate dynactin complex has been reported to
migrate as a 20S protein heteromultimer as resolved by
5–20% sucrose gradient sedimentation [11,12]. To test
whether EB1 was a component of the 20S dynactin
complex, we performed sedimentation analysis on a
5–40% sucrose gradient using Jurkat-cell extracts. This
demonstrated that most EB1 was not present in the 20S
dynactin complex. Instead, EB1 sedimented at 5S; a frac-
tion of p150Glued and CDIC also sedimented in those frac-
tions (Figure 2a). Immunoprecipitations were performed
from these sucrose fractions to test whether the cosedi-
mentation was a consequence of specific protein–protein
interactions. EB1 associated with p150Glued and CDIC in
fractions 10 and 11, in which all these cosediment, but not
in fractions 2 or 12, where they do not (Figure 2b). In frac-
tion 7, from which EB1 was absent, only as much p150Glued
was precipitated as could be precipitated by beads alone
with no antibody (data not shown). Immunoprecipitation
of p150Glued demonstrated association with EB1 in fraction
10 but not in fraction 6 (data not shown). Taken together,
these data demonstrate that the interaction between EB1,
CDIC, and p150Glued is specific. Elucidation of the stoi-
chiometry and proof of direct interactions between the
three proteins will require further experimentation.
EB1 was initially identified by its interaction with the
carboxy-terminal domain of the tumor suppressor protein
APC [1]. We investigated whether the association of EB1
with p150Glued was dependent on APC by performing
GST–EB1 precipitation experiments using cell extracts
from the colon-cancer cell lines HCT116 and SW480, which
express full-length and truncated forms of APC, respec-
tively. GST–EB1 associated with p150Glued in both of these
cell lines (Figure 3a), demonstrating that the
EB1–p150Glued association is not dependent on the carboxyl
terminus of APC. In addition, an anti-EB1 monoclonal anti-
body immunoprecipitated p150Glued and CDIC from both
cell lines (data not shown), demonstrating that this result
was not an artifact of GST precipitation. Sucrose density
gradient sedimentation analyses using extracts of both
HCT116 and SW480 cells demonstrated cosedimentation of
EB1 at 5S along with some of the p150Glued and CDIC (data
not shown). Immunoprecipitation with anti-APC antibodies
demonstrated that APC did not associate with p150Glued or
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Figure 1
The carboxy-terminal domain of EB1 associates with p150Glued, CDIC
and p50/dynamitin. (a) GST precipitations were performed from post-
nuclear lysates of 5 × 107 Jurkat cells that had been labeled in vivo
with 35S, using GST alone or GST–EB1 coupled to
glutathione–Sepharose beads. Post-nuclear lysates were made by
lysis in Buffer A (30 mM Hepes, 150 mM NaCl, 1% Triton X-100,
1 mM PMSF, 1 mM Na3PO4, 10 µg/ml leupeptin, 10 µg/ml aprotinin)
followed by centrifugation at 14,000 × g for 10 min. Precipitated
proteins were detected by autoradiography. The arrow marked
p150Glued indicates the position of a comparable band from unlabeled
lysates that was microsequenced. (b) Association of p150Glued with
EB1, but not with APC or α tubulin. Protein-G–Sepharose beads
(Pierce) bound to antibodies directed against EB1 (Oncogene
Research Products), APC (Ab-5, Oncogene Research Products), and
α tubulin (Sigma) were incubated with post-nuclear Jurkat-cell lysates
for 2 h, washed four times in Buffer A, and bound proteins were
solubilized. The immunoprecipitated proteins (IP) were resolved by
SDS–PAGE, and the gel was blotted onto poly(vinylidene difluoride)
membranes (PVDF; Millipore) and cut; the upper part of the blot was
probed with anti-p150Glued antiserum (gift of R. Vallee, Worcester
Foundation for Experimental Biology) and the lower part was probed
with the anti-EB1 monoclonal antibody. Note the detection of antibody
light chain(s). (c) CDIC associates with EB1 but not APC or α tubulin.
Jurkat-cell lysate and immunoprecipitations with antibodies directed
against EB1, APC (Ab-5) and α tubulin were separated by
SDS–PAGE and blotted. The membrane was cut and probed with
antisera to CDIC (DIC-70, Chemicon) or EB1. (d) Reciprocal immuno-
precipitation of EB1 using an anti-p150Glued antibody. Jurkat-cell post-
nuclear lysate, mock immunoprecipitation using nonspecific rabbit
immunoglobulin (Ig) G, and precipitation using anti-p150Glued antisera
were separated and blotted. The membrane was cut and probed with
anti-p150Glued antisera or anti-EB1 monoclonal antibody.
(e) Association of p50/dynamitin with EB1. Precipitations using the
full-length GST–EB1 fusion protein and GST alone, and Jurkat post-
nuclear lysate were separated and blotted. The blot was probed with
antisera to p50/dynamitin (murine anti-human p50, gift of R. Vallee;
top); the membrane was then stripped and re-probed with antisera
against GST (bottom). (f) The carboxyl terminus of EB1 interacts with
both p150Glued and CDIC. Jurkat-cell post-nuclear lysate and
precipitations using recombinant GST proteins fused to EB1 wild-type
(WT), EB1 amino-terminal domain (amino acids 1–135; NT), EB1
middle fragment (amino acids 69–202; M), EB1 carboxy-terminal
domain (amino acids 136–268; CT), or GST alone were separated
and blotted. The membrane was cut and probed with antisera to
p150Glued (top) and CDIC (bottom). 
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CDIC (Figure 3b), under conditions in which binding of
APC to β-catenin was preserved (Figure 3c). An anti-APC
monoclonal antibody also failed to precipitate EB1, which is
consistent with previous results in which the association
between APC and EB1 was shown only after overexpres-
sion of one of the proteins [1]. Taken together, these results
demonstrate that the 5S EB1 complex is not altered in cells
lacking the carboxy-terminal domain of APC. 
EB1, p150Glued, cytoplasmic dynein and APC have all
been shown to associate with microtubules [13–16]. To
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Figure 2
EB1 sediments predominantly at 5S in a
sucrose gradient and associates with p150Glued
and CDIC. (a) Fractions from a 12 ml linear
sucrose gradient (5–40%), centrifuged in a Ti
SW40 rotor (Beckman Instruments) at
35,000 rpm for 18 h at 4°C, were separated by
SDS–PAGE and blotted. The membrane was
cut and probed with antisera to p150Glued (top),
CDIC (middle) and anti-EB1 (bottom). The S
values of known standards are indicated.
(b) Immunoprecipitations from fractions 2, 10,
11 and 12 of the gradient shown in (a) were
performed using the anti-EB1 monoclonal
antibody. The blot was probed with the antisera
indicated on the left.
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Figure 3
The complex formed by EB1, p150Glued and CDIC is independent of
the carboxy-terminal domain of APC and of an intact microtubule
cytoskeleton. (a) Precipitations were performed from lysates of Jurkat
cells (J77), HCT116 cells (Oncogene Research Products) and
SW480 cells (American Type Culture Collection) using GST or
GST–EB1 fusion proteins. Precipitated proteins were separated and
the gel was blotted and probed with antisera directed against
p150Glued. (b–d) Lysates and anti-APC immunoprecipitations from
HCT116 and SW480 cells were analyzed. Two lysis detergents were
used, 1% NP-40 and 1% Triton X-100. The precipitated proteins were
divided into two aliquots. (b) The first aliquot was separated by
SDS–PAGE and blotted. The membrane was cut and probed with
antisera to p150Glued, CDIC, and EB1. (c) The blot in (b) was stripped
and reprobed with an antibody to β-catenin (Zymed) to demonstrate
the APC–β-catenin interaction. (d) The second aliquot was resolved by
3% agarose gel electrophoresis using Laemmli running buffer,
transferred to nitrocellulose by capillary action and probed with the
anti-APC monoclonal antibody Ab-1. Note that APC is truncated in
SW480 cells. The arrow indicates wild-type APC and the arrowhead
mutated APC. (e) The EB1–dynactin interaction is independent of
intact microtubules. Jurkat cells were treated with 10 µM nocodazole
(Sigma) for 1 h at 37°C to depolymerize microtubules and immediately
lysed in buffer A. Lysates and immunoprecipitations using an anti-EB1
monoclonal antibody from both untreated and nocodazole-treated cells
were separated and blotted. The membrane was cut and probed with
the antibodies indicated on the left. (f) Jurkat cells treated with
nocodazole as in (e) were lysed and subjected to 5–40% sucrose
gradient sedimentation. Twelve fractions were collected, separated
and blotted. The membrane was cut and probed with the indicated
antibodies. S values for known standards are shown.
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determine whether the protein interactions that we
observed were dependent upon an intact microtubule
array, Jurkat cells were treated with the microtubule-
depolymerizing drug nocodazole and subjected to
immunoprecipitation and sedimentation analyses. Co-
immunoprecipitation of EB1, CDIC and p150Glued was
not affected by nocodazole treatment (Figure 3e), suggest-
ing that this protein complex did not depend upon an
intact microtubule cytoskeleton. Immunofluorescence
analysis of cells from the same sample demonstrated the
absence of cytoplasmic microtubules after nocodazole
treatment (data not shown). Although the complex con-
taining EB1 remained intact after nocodazole treatment,
the sedimentation coefficient became smaller (< 5S;
Figure 3f), suggesting the loss of one or more, potentially
cytoskeletal-associated, components of the complex.
We have demonstrated specific associations between
human EB1 and both p150Glued and CDIC. Whether the
EB1 in the 5S fraction associates with each protein sepa-
rately or as an EB1–p150Glued–CDIC protein complex is
not known. Studies in yeast have pointed to a role of EB1-
related proteins in microtubule function. The S. pombe
EB1 homolog Mal3 was isolated in a screen for chromo-
some-loss mutations [3], whereas in S. cerevisiae, Bim1p
regulates microtubule dynamics and blocks cytokinesis if
the nucleus is mis-positioned by an act5 mutation ([5] and
our unpublished observations). Here, we have extended
these findings and demonstrated a biochemical associa-
tion in mammalian cells between EB1, dynactin complex
components and CDIC. The physical interaction of EB1
with members of the dynactin complex and the dynein
intermediate chain may form part of a checkpoint that
delays cytokinesis, allowing cell division events to be
accurately completed. Loss of the EB1–APC association
could be a mechanism by which APC mutations lead to
the chromosomal instability that is frequently observed in
colorectal cancers [17].
Supplementary material
Additional materials and methods are published with this article on
the internet.
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